Q-Line Biotech (NSE:QLINE) Other Stockholders Equity: ₹-0 Mil (As of Mar. 2025)


NSE:QLINE Q-Line Biotech Ltd NSE:QLINE
12 GF Score
Price ₹546.50
! 2 Warning Signs
View Full Analysis

What is Q-Line Biotech Other Stockholders Equity?

Q-Line Biotech NSE:QLINE -5.15% 12 Other Stockholders Equity is ₹-0 Mil as of Mar. 2025. GuruFocus rates NSE:QLINE with a GF Score™ of 12/100. The stock has 2 warning signs investors should review.

Q-Line Biotech's Other Stockholders Equity for the quarter that ended in Mar. 2025 was ₹-0 Mil.

Q-Line Biotech's quarterly Other Stockholders Equity stayed the same from Mar. 2023 (₹0 Mil) to Mar. 2024 (₹0 Mil) but then declined from Mar. 2024 (₹0 Mil) to Mar. 2025 (₹-0 Mil).

Q-Line Biotech's annual Other Stockholders Equity stayed the same from Mar. 2023 (₹0 Mil) to Mar. 2024 (₹0 Mil) but then declined from Mar. 2024 (₹0 Mil) to Mar. 2025 (₹-0 Mil).

Q-Line Biotech Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Q-Line Biotech's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Q-Line Biotech Other Stockholders Equity Chart

Q-Line Biotech Annual Data
Trend Mar23 Mar24 Mar25
Other Stockholders Equity
0.00 0.00 -0.00

Q-Line Biotech Semi-Annual Data
Mar23 Mar24 Mar25
Other Stockholders Equity 0.00 0.00 -0.00
NSE:QLINE
12GF Score
Q-Line Biotech Ltd NSE:QLINE
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Q-Line Biotech Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of ₹-0 Mil mean?
Q-Line Biotech (NSE:QLINE) has a Other Stockholders Equity of ₹-0 Mil as of Mar. 2025. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Q-Line Biotech and its competitors.
Is Q-Line Biotech's Other Stockholders Equity too high?
Q-Line Biotech's current Other Stockholders Equity is ₹-0 Mil. Overall, Q-Line Biotech has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Q-Line Biotech's Other Stockholders Equity compare to ABT and SYK?
Q-Line Biotech's Other Stockholders Equity of ₹-0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Devices & Instruments company?
A good Other Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Q-Line Biotech and its competitors. Q-Line Biotech's current Other Stockholders Equity is ₹-0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Q-Line Biotech stock overvalued right now?
Q-Line Biotech (NSE:QLINE) has a current Other Stockholders Equity of ₹-0 Mil. The current Other Stockholders Equity is ₹-0 Mil. Q-Line Biotech's overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Q-Line Biotech (NSE:QLINE), the current Other Stockholders Equity is ₹-0 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Q-Line Biotech Business Description

Address Kanpur Road Adjacent Transport Nagar Metro Station, 298-281, Transport Nagar, Lucknow, UP, IND, 226012
Q-Line Biotech Ltd is engaged in the business of developing, manufacturing and marketing of diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, distribution/supply of diagnostic equipment for different diagnostic healthcare needs. The company supplies diagnostic equipment and IVD products for different diagnostic healthcare needs directly or through its distributors majorly to diagnostic service providers, hospitals and medical colleges. It is engaged in Manufacturing and Trading into Biochemistry Regnant, Instruments and Consumables. The majority of revenue is derived from the Manufacturing segment.
12GF Score

Get the complete analysis for NSE:QLINE

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹546.50
Price